Composition neoFuragina Max 0.1g:

Active substance: furagin (furazidine). One tablet NeoFuragina contains 100 mg of furazidine and the other ingredients: lactose monohydrate, potato starch, sucrose, Polysorbate 80, stearic acid.

Operation neoFuragina Max 0.1g:

The nitrofuran derivative used in the drug, or furagin (furazidine), inhibits the multiplication of bacteria that are responsible for the development of infections in the lower urinary tract. The drug neoFuragina Max 01, g contains up to 100mg of furagin in each tablet.

NeoFuragina Application:
The neoFuragine Max 0.1g product is indicated for the treatment of lower urinary tract infections.

Additional information NeoFuragina Max:
Keep out of reach of children at room temperature. The drug NeoFuragina contains lactose and sucrose, therefore people with intolerance to some sugars should consult the use of the drug with a doctor.

NeoFuragina Max Contraindications:
Do not use in the case of hypersensitivity to any component of the drug and derivatives of nitrofuran. Do not use in the first trimester of pregnancy and during pregnancy (from the 38th week) and delivery, because there is a risk of hemolytic anemia in the newborn. Do not use in children and adolescents. Do not use in the case of confirmed renal failure (creatinine clearance below 60 ml / min or elevated serum creatinine). Do not use in the case of polyneuropathy and deficiency of glucose-6-phosphate dehydrogenase enzyme. It is not recommended for use during lactation.

Side effects:
Adverse reactions may occur during use. If you get the following side effects you should stop using the medicine immediately and see a doctor: (rarely) allergic reactions (rash, urticaria, pruritus, anaphylactic reactions - swelling of the face, lips, tongue, throat, difficulty in breathing and swallowing, urticaria, itching , anaphylactic shock, angioneurotic edema), severe skin reactions (erythema multiforme, exfoliative dermatitis, Stevens-Johnson syndrome), symptoms of drug-induced hepatitis, cholestatic jaundice, hepatic necrosis; (frequency unknown) asthmatic reactions (shortness of breath) in people with asthma, hypersensitivity reactions - acute reactions (with fever, chills, cough, chest pain, shortness of breath), chronic reactions (including: changes in the lungs); cyanosis as a result of methemoglobinemia (manifested by fatigability, dyspnoea, headache and dizziness, fast heart rate, drowsiness, coma); pseudomembranous colitis, peripheral nerve injury. Other side effects: (common) nausea, excessive gas donation, headaches; (frequency unknown) dizziness, drowsiness, blurred vision; vomiting, constipation, diarrhea, dyspepsia, abdominal pain, salivary gland inflammation, pancreatitis; baldness (transient); infection with furazidine resistant bacteria, fever, chills, malaise; in people with a deficiency of glucose-6-phosphate dehydrogenase, furazidine may lead to the development of megablastic or hemolytic anemia. accelerated heart activity, drowsiness, coma); pseudomembranous colitis, peripheral nerve injury.

NeoFuragina Other side effects: (common) nausea, excessive gas donation, headaches; (frequency unknown) dizziness, drowsiness, blurred vision; vomiting, constipation, diarrhea, dyspepsia, abdominal pain, salivary gland inflammation, pancreatitis; baldness (transient); infection with furazidine resistant bacteria, fever, chills, malaise; in people with a deficiency of glucose-6-phosphate dehydrogenase, furazidine may lead to the development of megablastic or hemolytic anemia. accelerated heart activity, drowsiness, coma); pseudomembranous colitis, peripheral nerve injury. Other side effects: (common) nausea, excessive gas donation, headaches; (frequency unknown) dizziness, drowsiness, blurred vision; vomiting, constipation, diarrhea, dyspepsia, abdominal pain, salivary gland inflammation, pancreatitis; baldness (transient); infection with furazidine resistant bacteria, fever, chills, malaise; in people with a deficiency of glucose-6-phosphate dehydrogenase, furazidine may lead to the development of megablastic or hemolytic anemia. blurred vision; vomiting, constipation, diarrhea, dyspepsia, abdominal pain, salivary gland inflammation, pancreatitis; baldness (transient); infection with furazidine resistant bacteria, fever, chills, malaise; in people with a deficiency of glucose-6-phosphate dehydrogenase, furazidine may lead to the development of megablastic or hemolytic anemia. blurred vision; vomiting, constipation, diarrhea, dyspepsia, abdominal pain, salivary gland inflammation, pancreatitis; baldness (transient); infection with furazidine resistant bacteria, fever, chills, malaise; in people with a deficiency of glucose-6-phosphate dehydrogenase, furazidine may lead to the development of megablastic or hemolytic anemia.

Dosage of neoFuragina tablets Max 0.1g:

Use as directed by your doctor or follow the instructions on the leaflet. It is recommended to take the medicine NeoFuragina orally during a meal that contains protein (the protein increases the absorption of furagina). Drink plenty of fluids. Dosage schedule in adults: first day of treatment: take one tablet 4 times a day. From the 2nd to the 8th day of treatment: take one tablet 3 times a day. Treatment usually takes 7-8 days. The treatment can be repeated if necessary, but only after a 10-15-day break.